1. Mosqueda-Taylor A. New findings and controversies in odontogenic tumors. Med Oral Patol Oral Cir Bucal. 2008;13:18758398.

2. da Silva LP, Serpa MS, Santana T, do Nascimento GJF, de Souza Andrade ES, Sobral APV. Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study. Eur Arch Oto-Rhino-Laryngology. 2016;274:1089–95.
https://doi.org/10.1007/s00405-016-4348-z
PMid:27747382

3. Wright JM, Vered M. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. Head Neck Pathol. 2017;11:68–77.
https://doi.org/10.1007/s12105-017-0794-1
PMid:28247226

4. Tekkesin MS, Mutlu S, Olgac V. Expressions of bax, bcl-2 and ki-67 in odontogenic keratocysts (keratocystic odontogenic tumor) in comparison with ameloblastomas and radicular cysts. Turkish J Pathol. 2012;28:49.
https://doi.org/10.5146/tjpath.2012.01097
PMid:22207432

5. Lee SK, Kim YS. Current concepts and occurrence of epithelial odontogenic tumors: I. Ameloblastoma and adenomatoid odontogenic tumor. Korean J Pathol. 2013;47:191–202.
https://doi.org/10.4132/KoreanJPathol.2013.47.3.191
PMid:23837011 PMCid:PMC3701814

6. Gu XM, Zhao LS, Sun LS, Li TJ. PTCH Mutations in Sporadic and. Biotechnology. 2006;85:859–63.

7. Garg K, Chandra S, Raj V, Fareed W, Zafar M. Molecular and genetic aspects of odontogenic tumors: A review. Iran J Basic Med Sci. 2015;18:529–36.
PMid:26221475 PMCid:PMC4509946

8. Garcia P, Attardi L. Illuminating p53 function in cancer with genetically engineered mouse models. Semin Cell Dev Biol. 2014;0:74–85.
https://doi.org/10.1016/j.semcdb.2013.12.014
PMid:24394915 PMCid:PMC4035469

9. Bagulkar BB, Gawande M, Chaudhary M, Gadbail AR, Patil S, Bagulkar S. XIAP and Ki-67: A Correlation between antiapoptotic and proliferative marker expression in benign and malignant tumours of salivary gland: An immunohistochemical study. J Clin Diagnostic Res. 2015;9:EC01-EC04.
https://doi.org/10.7860/JCDR/2015/11690.5604

10. Sauk JJ, Nikitakis NG, Scheper MA. Are we on the brink of nonsurgical treatment for ameloblastoma? Oral Surgery, Oral Med Oral Pathol Oral Radiol Endodontology. 2010;110:68–78.
https://doi.org/10.1016/j.tripleo.2010.01.024
PMid:20418126

11. Salehinejad J, Zare-Mahmoodabadi R, Saghafi S, Jafarian AH, Ghazi N, Rajaei AR, et al. Immunohistochemical detection of p53 and PCNA in ameloblastoma and adenomatoid odontogenic tumor. J Oral Sci. 2011;53(2):213–7.
https://doi.org/10.2334/josnusd.53.213
PMid:21712626

12. Shetty DC, Urs AB, Godhi S, Gupta S. Classifying odontogenic keratocysts as benign cystic neoplasms: a molecular insight into its aggressiveness. J Maxillofac Oral Surg. 2010;9:30–4.
https://doi.org/10.1007/s12663-010-0010-2
PMid:23139563 PMCid:PMC3453704

13. Sajeevan TP, Saraswathi TR, Ranganathan K, Joshua E, Rao UDK. Immunohistochemical study of p53 and proliferating cell nuclear antigen expression in odontogenic keratocyst and periapical cyst. J Pharm Bioallied Sci. 2014;6:S52-7.
https://doi.org/10.4103/0975-7406.137388
PMid:25210385 PMCid:PMC4157281

14. Deyhimi P, Hashemzade Z. Comparative study of TGF-alpha and P53 markers' expression in odontogenic keratocyst and orthokeratinaized odontogenic cyst. Dent Res J (Isfahan). 2012;9:S39-44.

15. Razavi SM, Tabatabaie SH, Hoseini AT, Hoseini ET, Khabazian A. A comparative immunohistochemical study of Ki-67 and Bcl-2 expression in solid ameloblastoma and adenomatoid odontogenic tumor. Dent Res J (Isfahan). 2012;9:192-7.
https://doi.org/10.4103/1735-3327.95235

16. Sindura C, Babu C, Mysorekar V, Kumar V. Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor. J Oral Maxillofac Pathol. 2013;17:176–80.
https://doi.org/10.4103/0973-029X.119750
PMid:24250074 PMCid:PMC3830222

17. Sreedhar G, Raju MV, Metta KK, Manjunath S, Shetty S, Agarwal RK. Immunohistochemical analysis of factors related to apoptosis and cellular proliferation in relation to inflammation in dentigerous and odontogenic keratocyst. J Nat Sci Biol Med. 2014;5:112–5.
https://doi.org/10.4103/0976-9668.127300
PMid:24678208 PMCid:PMC3961914

18. Amaral FR, Mateus GCP, Bonisson LA, de Andrade BAB, Mesquita RA, Horta MCR, et al. Cell proliferation and Apoptosis in Ameloblastomas and keratocystic odontogenic tumors. Braz Dent J. 2012;23:91–6.
https://doi.org/10.1590/S0103-64402012000200001
PMid:22666764

19. González-González R, Molina-Frechero N, Damian-Matsumura P, Salazar-Rodriguez S, Bologna-Molina R. Immunohistochemical expression of Survivin and its relationship with cell apoptosis and proliferation in ameloblastomas. Dis Markers. 2015;2015:301781.
https://doi.org/10.1155/2015/301781
PMid:25866434 PMCid:PMC4381570

20. Rangiani A, Motahhary P. Evaluation of bax and bcl-2 expression in odontogenic keratocysts and orthokeratinized odontogenic cysts: A comparison of two cysts. Oral Oncol. 2009;45:e41-4.
https://doi.org/10.1016/j.oraloncology.2008.12.007
PMid:19362040